Close menu

July 7th, 2022 | 14:13 CEST

K+S AG, Viva Gold, Rheinmetall, Hensoldt - Recession fears across the board

  • Gold
  • Defense
  • Investments
Photo credits:

Increasing fears of a global recession are sending the capital markets into a tailspin. The DAX marked a new low for the year at 12,385 points, while the euro fell to its lowest level in almost 20 years against the US dollar due to weak economic data from the eurozone. In addition to the oil price, which has been booming for weeks, the precious metals markets also took a beating, with gold breaking below the psychologically important support zone at USD 1,800. Due to the partly exaggerated price reactions, however, there are long-term anti-cyclical buying opportunities.

time to read: 3 minutes | Author: Stefan Feulner
ISIN: K+S AG NA O.N. | DE000KSAG888 , VIVA GOLD CORP. | CA92852M1077 , RHEINMETALL AG | DE0007030009 , HENSOLDT AG INH O.N. | DE000HAG0005

Table of contents:

    Gold and silver on the downswing

    The firm reserve currency, the US dollar, which reached its highest level in almost 20 years against the euro, contributed significantly to a further sell-off on the precious metals market. It first pushed the gold price below the psychologically important USD 1,800 mark and then below the support zone at USD 1,780 per troy ounce of gold. Although both the geopolitical environment and macroeconomic data support a rising gold price long-term, the precious metals sector is still ticked off in the short term. According to Elliott Wave experts, the market is currently in the final correction wave, resulting in the target area between USD 1,600 and USD 1,680. Then the chartists see a bottoming out and long-term rising prices, resulting in new highs.

    Gold producers such as Barrick and Newmont are also still in correction mode. In contrast, smaller gold exploration companies have already advanced significantly again and should offer attractive long-term anticyclical entry opportunities at current levels. Viva Gold, a Vancouver-based exploration company, traded in Frankfurt in addition to Toronto and the OTCQB, corrected 83% since the August 2020 gold high. But the performance of the 100% owned Tonopah Gold Project is heading in a positive direction. The 4,250-hectare property is located on the Walker Lane trend in Nevada, known for high mineralization. Nevada was named the world's #3 best gold deposit in 2021 by the Fraser Institute. Just 30km from Tonopah is Kinross' Round Mountain mine, which produced 258k ounces of gold in 2021.

    An attractive explorer at a cheap level

    In the process, Viva Gold's flagship project has a pit-limited measured and indicated gold mineral resource of 394,000 ounces grading 0.78 g/t gold and 206,000 ounces of inferred resources at 0.87 g/t. Viva is now driving the project towards the feasibility study and approval process. A new drill program of up to 2,000m and 10 holes has now commenced, with drilling focused on the western and eastern portions of the main deposit.

    The stock market value of Viva Gold has shrunk to around EUR 5.20 million. If the results are positive, the feasibility study is started, and the gold price picks up in the long term, the Company could outperform. On a positive note, 56% of the shares are in fixed hands.

    Back on track at K+S

    When the Russian army invaded Ukraine at the end of February, stock markets collapsed across the board, with the DAX losing around 20%. However, as previously observed during the Corona pandemic, when vaccine producers and e-commerce-related stocks were among the winners, even in the worst state of war, there were companies that managed to double in value within a few days. These included armaments companies such as Rheinmetall and Hensoldt, which had been described as "socially harmful" just a short time before, as well as companies that profited from the sanctions imposed on Russian and Belarusian companies. The Kassel-based fertilizer producer K+S, the world's number five potash producer, was one of these profiteers.

    As a result of the sanctions against Uralkali and Belaruskali, we reported in detail at the report on, which were responsible for about one-third of potash production in recent years, Western suppliers now had to make up for the mighty supply gap. With a view to a dazzling full year, forecasts for the year had already been raised in March. The MDAX member now expects a strong increase in operating profit between EUR 1.6 billion and EUR 1.9 billion. In the 2021 annual report, CEO Lohr also addressed longer-term goals. Thus, from 2023 onwards, the K+S Group and each individual plant should generate positive free cash flow even if potash prices are temporarily low. Over a 5-year cycle, the cost of capital is to be earned with an EBITDA margin of more than 20%.

    The price of potash, which exploded due to the invasion and the declared sanctions, has been consolidating for weeks, and the gas required has also lost around 40% since the highs this year. The K+S share lost even more ground. Since the Russian invasion, the share had almost doubled from around EUR 19 to EUR 36.50. However, due to the current market correction, the share price lost its entire upward movement again. The next support area is the upward trend formed in October 2020 at EUR 17.70. The major Swiss bank UBS sees the share of the potash producer in higher territory and reiterated the price target of EUR 30 and the investment rating at "neutral".

    Fears of a pending global recession are causing almost all asset classes to tumble. The shares of the recently hyped potash producer K+S should become interesting again at the current level. Anticyclically, exploration companies such as Viva Gold are also an attractive long-term opportunity. In contrast, the correction in defense companies is likely to continue.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author

    Related comments:

    Commented by Juliane Zielonka on September 29th, 2023 | 07:00 CEST

    Defence Therapeutics, Schott Pharma, Allianz Group: Focus on Innovation, Growth and Portfolio Optimization

    • Biotechnology
    • Pharma
    • Investments

    According to a recent study, biotech company Defence Therapeutics achieves twice the immune response of conventional mRNA therapies with its Accum® mRNA technology. That translates to fewer side effects and a more effective treatment. According to Precedence Research, the market size for mRNA therapeutics is projected to reach approximately USD 137.59 billion by 2032. It is expected to grow at a CAGR of 13.2% from 2023 to 2032. In order to inject these active ingredients, precision-fit medical vials are required, and Schott Pharma is ensuring this with their IPO launched on the German stock exchange this week, which could bring a valuation of around EUR 4 billion. The Allianz Group, on the other hand, is focusing on consolidation, selling its business in the Middle East and thus flushing around EUR 210 million cash into its coffers.


    Commented by André Will-Laudien on September 28th, 2023 | 08:05 CEST

    Attention: Extended correction - Buy the right stocks now! Bayer, Viva Gold, TUI, and BASF are on the list!

    • Mining
    • Gold
    • Pharma
    • chemicals
    • travel

    Higher inflation and rising interest rates - this connection should be clear to investors. The interest rate level in Germany has moved from negative territory to 2.77% in the 10-year range, but stocks continued to rise cheerfully. The party led to all-time highs of 16,528 points in July, but the fundamental situation of the companies deteriorated in parallel. Only after repeated warnings from the US Federal Reserve did the explosive NASDAQ also enter a correction. And it continues. Yesterday, the CEO of US investment bank JPMorgan, Dimon, warned that the world may not be prepared for 7% capital market interest rates. He and Dr. Jens Erhardt, the CEO of the asset management company DJE, warn of stronger setbacks on the stock markets. Some stocks have already undergone a strong correction. Here is a brief overview.


    Commented by André Will-Laudien on September 26th, 2023 | 07:45 CEST

    Artificial Intelligence in Sellout! Nvidia, Defense Metals, ARM Holdings - Nothing works without rare earths!

    • Mining
    • RareEarths
    • AI
    • chips
    • Investments

    After long bull market movements, the stock market usually tends to rotate sectors, or the market enters a general consolidation. In the former case, investors can profit by reallocating their assets while exploring new investment opportunities. In the latter case, all stocks come down, and the capital market generally suffers from a change in sentiment and corrects recently exaggerated valuations. In the case of the new megatrend of Artificial Intelligence (AI), the stock market seems to sense a great need for correction. As if by magic, the blockbuster stock Nvidia rose by 250% in just 9 months. However, it has already retraced nearly 20% from its peak. Where do the opportunities lie for investors?